• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后的血清乳酸脱氢酶活性(作者译)

[Serum lactate dehydrogenase activity after renal transplantation (author's transl)].

作者信息

Schmidt P, Zazgornik J, Kopsa H, Balcke P, Pils P, Bayer P M

出版信息

Wien Klin Wochenschr. 1977 Dec 23;89(24):819-21.

PMID:339555
Abstract

Regular 4-weekly follow-up controls of serum lactate dehydrogenase activity in 23 renal transplant recipients revealed a constant rise in serum LDH activity during the early postoperative months. During the first post-transplant month serum LDH activity increased from 150.0 +/- 48.2 mE/ml to 195.5 +/- 84.8 mE/ml, serum enzyme activity being highest (329.1 +/- 143.2 mE/ml) 6 months after surgery. Since serum creatinine levels remained relatively constant, it seems unlikely that renal rejection played a major pathogenic role in the production of increased LDH activity. Since the pattern of lactate dehydrogenase isoenzymes was ithin normal limits, the pathogenesis of increased LDH serum activity following renal transplantation is not yet clear. Possible causes such as liver damage due to hepatitis B, macrocytosis induced by immunosuppressive therapy and myopathy to steroids are discussed.

摘要

对23名肾移植受者进行定期的每4周一次的血清乳酸脱氢酶活性随访监测,结果显示术后早期血清乳酸脱氢酶活性持续升高。移植后的第一个月,血清乳酸脱氢酶活性从150.0±48.2 mE/ml升至195.5±84.8 mE/ml,术后6个月时血清酶活性最高(329.1±143.2 mE/ml)。由于血清肌酐水平保持相对稳定,肾排斥反应似乎不太可能在乳酸脱氢酶活性升高的产生中起主要致病作用。由于乳酸脱氢酶同工酶模式在正常范围内,肾移植后血清乳酸脱氢酶活性升高的发病机制尚不清楚。文中讨论了可能的原因,如乙型肝炎导致的肝损伤、免疫抑制治疗引起的大细胞性贫血以及对类固醇的肌病反应。

相似文献

1
[Serum lactate dehydrogenase activity after renal transplantation (author's transl)].肾移植后的血清乳酸脱氢酶活性(作者译)
Wien Klin Wochenschr. 1977 Dec 23;89(24):819-21.
2
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.肾移植中他克莫司与环孢素A微乳剂相比的疗效和安全性:2年随访结果
Nephrol Dial Transplant. 2005 May;20(5):968-73. doi: 10.1093/ndt/gfh739. Epub 2005 Mar 1.
3
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.肾移植患者从钙调神经磷酸酶抑制剂转换为西罗莫司后出现移植肾功能障碍的长期结果。
Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. doi: 10.1093/ndt/gfh957. Epub 2005 Jun 28.
4
[Diagnostic and pathogenetic significance of determining lactate dehydrogenase isoenzyme activity in various biological media in patients with viral hepatitis].[病毒性肝炎患者不同生物介质中乳酸脱氢酶同工酶活性测定的诊断及发病机制意义]
Ter Arkh. 1987;59(2):89-94.
5
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.FK506治疗难治性肾移植排斥反应:来自肝移植的经验教训。
Clin Transplant. 1996 Aug;10(4):323-32.
6
Immunosuppression in live-related donor renal transplantation.活体亲属供肾移植中的免疫抑制
Natl Med J India. 2001 Mar-Apr;14(2):75-80.
7
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.在肾移植受者中使用达利珠单抗桥接疗法转换为基于西罗莫司的维持性免疫抑制治疗。
Clin Transplant. 2004;18 Suppl 12:61-6. doi: 10.1111/j.1399-0012.2004.00220.x.
8
Time-dependent variations in urine output after renal transplantation.肾移植术后尿量的时间依赖性变化。
Transplant Proc. 2007 May;39(4):932-3. doi: 10.1016/j.transproceed.2007.04.006.
9
Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Clin Transplant. 1997 Feb;11(1):1-8.
10
Diminished serum folic acid levels in renal transplant recipients.肾移植受者血清叶酸水平降低
Clin Nephrol. 1982 Dec;18(6):306-10.